Swedish Orphan Biovitrum Future Growth
Future criteria checks 4/6
Swedish Orphan Biovitrum is forecast to grow earnings and revenue by 25.9% and 9.3% per annum respectively. EPS is expected to grow by 26.7% per annum. Return on equity is forecast to be 13.8% in 3 years.
Key information
25.9%
Earnings growth rate
26.7%
EPS growth rate
Biotechs earnings growth | 44.0% |
Revenue growth rate | 9.3% |
Future return on equity | 13.8% |
Analyst coverage | Good |
Last updated | 17 Jul 2024 |
Recent future growth updates
Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 19Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Recent updates
Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 19Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Jun 24Here's Why Shareholders May Consider Paying Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) CEO A Little More
May 08Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Investors Still Waiting For A Pull Back In Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Apr 24Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Swedish Orphan Biovitrum's (STO:SOBI) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 15Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) Earnings Haven't Escaped The Attention Of Investors
Jan 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Jan 11These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 28Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jun 26Swedish Orphan Biovitrum (STO:SOBI) Has A Somewhat Strained Balance Sheet
Mar 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 31,072 | 6,704 | 8,500 | 9,418 | 8 |
12/31/2025 | 27,527 | 4,847 | 7,007 | 7,652 | 11 |
12/31/2024 | 24,938 | 3,394 | 6,030 | 6,751 | 8 |
6/30/2024 | 23,710 | 2,145 | 5,056 | 6,716 | N/A |
3/31/2024 | 23,140 | 2,142 | 2,313 | 4,743 | N/A |
12/31/2023 | 22,123 | 2,409 | -473 | 4,470 | N/A |
9/30/2023 | 21,270 | 2,769 | 832 | 5,380 | N/A |
6/30/2023 | 20,100 | 3,125 | 120 | 4,977 | N/A |
3/31/2023 | 19,104 | 3,162 | 337 | 4,915 | N/A |
12/31/2022 | 18,790 | 2,638 | 3,099 | 4,576 | N/A |
9/30/2022 | 17,696 | 2,493 | 3,145 | 4,804 | N/A |
6/30/2022 | 17,458 | 2,516 | 3,363 | 4,317 | N/A |
3/31/2022 | 16,793 | 2,526 | 4,979 | 5,415 | N/A |
12/31/2021 | 15,529 | 2,679 | 5,100 | 5,470 | N/A |
9/30/2021 | 15,214 | 2,940 | 1,405 | 4,066 | N/A |
6/30/2021 | 14,424 | 2,744 | 378 | 4,190 | N/A |
3/31/2021 | 14,283 | 2,759 | 819 | 4,739 | N/A |
12/31/2020 | 15,261 | 3,245 | 1,074 | 4,926 | N/A |
9/30/2020 | 15,570 | 3,103 | 3,101 | 5,185 | N/A |
6/30/2020 | 15,530 | 3,367 | 5,747 | 5,799 | N/A |
3/31/2020 | 15,622 | 3,583 | 5,176 | 5,132 | N/A |
12/31/2019 | 14,248 | 3,304 | -5,171 | 3,634 | N/A |
9/30/2019 | 11,929 | 2,539 | -4,868 | 3,195 | N/A |
6/30/2019 | 11,313 | 2,620 | -6,526 | 2,912 | N/A |
3/31/2019 | 10,440 | 2,806 | -7,233 | 2,201 | N/A |
12/31/2018 | 9,139 | 2,418 | 1,512 | 2,090 | N/A |
9/30/2018 | 8,443 | 2,181 | 1,217 | 1,810 | N/A |
6/30/2018 | 7,729 | 1,881 | 1,589 | 1,678 | N/A |
3/31/2018 | 7,079 | 1,462 | N/A | 1,287 | N/A |
12/31/2017 | 6,511 | 1,149 | N/A | 1,333 | N/A |
9/30/2017 | 5,927 | 865 | N/A | 1,103 | N/A |
6/30/2017 | 5,497 | 677 | N/A | 604 | N/A |
3/31/2017 | 5,327 | 703 | N/A | 431 | N/A |
12/31/2016 | 5,204 | 802 | N/A | 343 | N/A |
9/30/2016 | 4,727 | 716 | N/A | 329 | N/A |
6/30/2016 | 4,341 | 585 | N/A | 493 | N/A |
3/31/2016 | 3,636 | 291 | N/A | 573 | N/A |
12/31/2015 | 3,228 | 65 | N/A | 507 | N/A |
9/30/2015 | 3,119 | 59 | N/A | 547 | N/A |
6/30/2015 | 3,000 | 108 | N/A | 426 | N/A |
3/31/2015 | 2,899 | 136 | N/A | 268 | N/A |
12/31/2014 | 2,607 | -268 | N/A | 234 | N/A |
9/30/2014 | 2,513 | -263 | N/A | 185 | N/A |
6/30/2014 | 2,364 | -373 | N/A | 86 | N/A |
3/31/2014 | 2,221 | -410 | N/A | 189 | N/A |
12/31/2013 | 2,177 | -93 | N/A | 185 | N/A |
9/30/2013 | 2,038 | -222 | N/A | 339 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SOBI's forecast earnings growth (25.9% per year) is above the savings rate (1%).
Earnings vs Market: SOBI's earnings (25.9% per year) are forecast to grow faster than the Swedish market (15.1% per year).
High Growth Earnings: SOBI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SOBI's revenue (9.3% per year) is forecast to grow faster than the Swedish market (1% per year).
High Growth Revenue: SOBI's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SOBI's Return on Equity is forecast to be low in 3 years time (13.8%).